Zhejiang Dayang Biology Technology Co.,Ltd.
003017.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.92 | -1.05 | 1.04 | -0.43 |
| FCF Yield | 0.18% | 4.01% | -0.79% | -7.16% |
| EV / EBITDA | 10.34 | 14.91 | 14.31 | 14.70 |
| Quality | ||||
| ROIC | 4.64% | 4.34% | 4.51% | 6.10% |
| Gross Margin | 19.55% | 18.08% | 13.82% | 19.43% |
| Cash Conversion Ratio | 1.04 | 3.65 | 1.14 | -0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.90% | 5.49% | 15.97% | 8.00% |
| Free Cash Flow Growth | -96.52% | 717.30% | 90.07% | -942.72% |
| Safety | ||||
| Net Debt / EBITDA | 0.03 | -1.08 | 1.23 | 0.38 |
| Interest Coverage | 10.34 | 8.43 | 9.82 | 19.06 |
| Efficiency | ||||
| Inventory Turnover | 6.11 | 4.95 | 7.19 | 3.90 |
| Cash Conversion Cycle | 31.97 | 23.24 | 57.21 | 69.76 |